Company profile
D2M Biotherapeutics company profile
D2M Biotherapeutics focuses on the development of novel immunotherapeutics. The company is a tumor immunological drug developer that aims to expand the potential of immunotherapy.
Business identity
- Phone number
- (617)586-5012
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Founded
- 2019-01-01, Year
Headquarters
- Headquarters
- George Town, George Town, Cayman Islands
- Country code
- KY
- Continent
- North America